Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinic Efficacy of Immunoglobulin Anti-RhD KamRho-D® (Panamerican) in Postpartum Immunization of Rh and Coombs Negative Women at Sensitization Risk.

NCT01666249 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.

NCT NCT01666249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinic Efficacy of Immunoglobulin Anti-RhD KamRho-D® (Panamerican) in Postpartum Immunization of Rh and Coombs Negative Women at Sensitization Risk.
Lead sponsor
Azidus Brasil
Phase
Phase 3
Overall status
Suspended
Start date
April 30, 2014
Completion date
December 31, 2020
Enrollment
347 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy; fetomaternal hemorrhage